Diabetes Intervention for Agenda Trial: study of the efficacy of a patient-orientated agenda (produced by the PACE-D tool) for use in a diabetes clinical consultation

Conditions

Topic: Diabetes Research Network

Julia Frost, Andy Gibson, Obioha C. Ukoumunne, Bijay Vaidya, Nicky Britten

BMJ Open2019-06-019 citations

10.1136/bmjopen-2018-026588

A preconsultation web-based tool to generate an agenda for discussion in diabetes outpatient clinics to improve patient outcomes (DIAT): a feasibility study

Obioha C. Ukoumunne, Bijay Vaidya, Julia Frost, Rob Anderson, Catherine Argyle et al. (13 authors)

BMJ Open2017-03-0113 citations

10.1136/bmjopen-2016-013519

A pilot randomised controlled trial of a preconsultation web-based intervention to improve the care quality and clinical outcomes of diabetes outpatients (DIAT)

Julia Frost, Rob Anderson, Catherine Argyle, Mark Daly, Faith Harris‐Golesworthy et al. (13 authors)

BMJ Open2013-07-018 citations

10.1136/bmjopen-2013-003396

Interventions

Interventions as of 08/07/2016: The intervention has been designed to facilitate the articulation of patients’ often unvoiced agendas which arise from their continual efforts to manage

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. People with type 1 or type 2 diabetes mellitus 2. Due to attend for hospital outpatient appointment 3. Aged 18 and over 4. Basic written and spoken English (to complete outcome measures)

Exclusion criteria

Exclusion criteria: 1. People with gestational diabetes 2. People receiving insulin pump therapy

Design outcomes

Primary

Measure	Time frame
Blood glucose is measured by measuring glycosylated haemoglobin (HbA1c) at baseline and 6 months.	—

Secondary

Measure	Time frame
1. Quality of life is measured using the Audit of Diabetes-Dependent Quality of life at baseline and 6 months 2. Resource use is measured using the Client Services Receipt Inventory at baseline and 6 months 3. Empowerment is measured using the Diabetes Empowerment Scale at baseline and 6 months 4. Self care activities are measured using the Diabetes Self-Care Activity Questionnaire at baseline and 6 months 5. Treatment satisfaction is measured using the Diabetes Treatment Satisfaction Questionnaire (‘status’ and ‘change’ versions) at baseline and 6 months 6. Quality of life is measured using the EuroQol-5L at baseline and 6 months 7. Enablement is measured using the Patient Enablement Instrument at baseline and 6 months 8. Communication is measured using the Patient Report of Communication at baseline and 6 months 9. Use of medication is self-reported by patients at baseline and 6 months 10. Qualitative interviews will be conducted with participating staff and patients in order to capture patient and staff perspectives	—

Measure

Time frame

1. Quality of life is measured using the Audit of Diabetes-Dependent Quality of life at baseline and 6 months 2. Resource use is measured using the Client Services Receipt Inventory at baseline and 6 months 3. Empowerment is measured using the Diabetes Empowerment Scale at baseline and 6 months 4. Self care activities are measured using the Diabetes Self-Care Activity Questionnaire at baseline and 6 months 5. Treatment satisfaction is measured using the Diabetes Treatment Satisfaction Questionnaire (‘status’ and ‘change’ versions) at baseline and 6 months 6. Quality of life is measured using the EuroQol-5L at baseline and 6 months 7. Enablement is measured using the Patient Enablement Instrument at baseline and 6 months 8. Communication is measured using the Patient Report of Communication at baseline and 6 months 9. Use of medication is self-reported by patients at baseline and 6 months 10. Qualitative interviews will be conducted with participating staff and patients in order to capture patient and staff perspectives

—

Countries

United Kingdom

Outcome results

None listed